Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia

Abstract : BACKGROUND AND AIMS: Familial hypobetalipoproteinemia (FHBL) is a co-dominant disorder characterized by decreased plasma levels of LDL-cholesterol and apolipoprotein B (ApoB). Currently, genetic diagnosis in FHBL relies largely on Sanger sequencing to identify APOB and PCSK9 gene mutations and on western blotting to detect truncated ApoB species. METHODS: Here, we applied targeted enrichment and next-generation sequencing (NGS) on a panel of three FHBL genes and two abetalipoproteinemia genes (APOB, PCSK9, ANGPTL3, MTTP and SAR1B). RESULTS: In this study, we identified five likely pathogenic heterozygous rare variants. These include four novel nonsense mutations in APOB (p.Gln845*, p.Gln2571*, p.Cys2933* and p.Ser3718*) and a rare variant in PCSK9 (Minor Allele Frequency \textless0.1%). The affected family members tested were shown to be carriers, suggesting co-segregation with low LDL-C. CONCLUSIONS: Our study further demonstrates that NGS is a reliable and practical approach for the molecular screening of FHBL-causative genes that may provide a mean for deciphering the genetic basis in FHBL.
Type de document :
Article dans une revue
Atherosclerosis, 2016, Equipe 3 Equipe 4 Equipe 5, 250, pp.52--56. 〈10.1016/j.atherosclerosis.2016.04.010〉
Liste complète des métadonnées

Littérature citée [4 références]  Voir  Masquer  Télécharger

https://hal.archives-ouvertes.fr/hal-01831745
Contributeur : Stephanie Chatel <>
Soumis le : jeudi 12 juillet 2018 - 15:26:40
Dernière modification le : lundi 30 juillet 2018 - 10:06:22
Document(s) archivé(s) le : lundi 15 octobre 2018 - 16:27:49

Fichier

1-s2.0-S0021915016301411-main....
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Antoine Rimbert, Matthieu Pichelin, Simon Lecointe, Marie Marrec, Solena Le Scouarnec, et al.. Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia. Atherosclerosis, 2016, Equipe 3 Equipe 4 Equipe 5, 250, pp.52--56. 〈10.1016/j.atherosclerosis.2016.04.010〉. 〈hal-01831745〉

Partager

Métriques

Consultations de la notice

53

Téléchargements de fichiers

11